https://rjrindex.com/articles/five-year-follow-up-results-from-the-phase-3-keynote-564-study-of-adjuvant-pembrolizumab-pembro-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-psagt02-after-6-12-months-treatment-for-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cobolimab-and-dostarlimab-in-the-first-line-treatment-of-unresectable-hepatoma-a-multi-center-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-mrna-car-therapy-correlative-biomarker-analysis-from-the-mt-302-phase-1-study-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dm005-an-anti-egfrc-met-bispecific-antibody-drug-conjugate-for-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-to-predict-outcome-after-177lulu-psma-for-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-year-end-holidays-on-delayed-cancer-diagnoses-and-survival-implications-a-population-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hemoglobin-level-and-neutrophil-to-lymphocyte-ratio-as-prognostic-peripheral-blood-markers-of-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-disability-adjusted-life-years-dalys-and-mortality-of-pancreatic-cancer-among-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-and-clusters-exhibiting-expression-of-pd-l1-in-colorectal-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aren1721-a-randomized-phase-2-trial-of-axitinibnivolumab-combination-therapy-vs-single-agent-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-provider-experiences-with-telehealth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-gamma-ray-precision-effect-of-convolutional-neural-networks-on-chemotherapy-side-effects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-us-neuroendocrine-tumor-clinical-trial-enrollment-over-the-past-qua 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-in-aya-survivorship-clinical-settings-best-practices-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-analysis-of-a-randomized-phase-ii-study-of-front-line-chemo-immunotherapy-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-course-of-dmmr-endometrial-cancer-in-real-world-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-host-genetic-variants-determining-bifidobacterium-abundance-in-the-lactose-metab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-immunotherapy-versus-chemotherapy-on-mortality-and-adverse-events-in-cancer-patients-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-age-frailty-status-and-comorbidity-status-with-post-operative-outcomes-following-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-plus-oxaliplatin-and-capecitabine-versus-sintilimab-plus-albumin-bound-paclitaxel-and-cap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-mortality-of-endometrial-cancer-in-appalachian-eastern-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-data-driven-physician-engagement-and-effects-on-patient-recruitment-for-clinical-trial-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancers-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-outcomes-of-intravenous-immunoglobulin-ivig-in-treatment-of-steroid-refractory-immune-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-as-cytoreductive-therapy-in-high-risk-acute-promyelocytic-leukemia-a-potential-alternati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-endocrine-therapy-naet-versus-neoadjuvant-chemotherapy-nac-in-stage-ii-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cupid-sup64sup-cu-tlx592-phase-i-pk-biodistribution-and-dosimetry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplantation-in-chronic-myelomonocytic-leukemia-analysis-of-post-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alter-pa001-a-multicenter-randomized-study-of-anlotinib-and-benmelstobart-in-combination-with-ag-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-diagnostic-accuracy-and-tumor-uptake-of-68ga-fapi-petct-versus-18f-fdg-petct-for-detec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-due-to-pulmonary-embolism-in-female-patients-with-genital-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-tumor-evolution-in-advanced-ovarian-cancer-proteogenomic-insights-before-and-after-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-immunotherapy-treatments-in-non-small-cell-lung-cancer-nsclc-using-novel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-disparities-in-merkel-cell-carcinoma-mcc-in-immune-checkpoint-inhibitor-ici-era-a-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-unresectable-stage-iii-or-stage-iv-melanoma-refractory-to-immune-checkpoint-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-on-phase-iii-pivotal-trial-of-bria-imt-cpi-vs-physicians-choice-in-advanced-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-set-enrichment-analysis-of-oral-cavity-carcinoma-to-identify-pathways-associated-with-lymph-nod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neurocognitive-impairment-and-financial-hardship-in-adult-survivors-of-childhood-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-telomere-targeting-agent-thio-sequenced-with-cemiplimab-in-third-line-immune-checkp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-of-a-role-for-oropharyngeal-cancer-cells-with-low-hpv-gene-expression-in-treatment-failure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-decision-impact-study-of-the-breast-cancer-index-results-from-the-bci-registry-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/applications-of-artificial-intelligence-in-oncology-patient-education-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-and-collaboration-in-a-dedicated-young-onset-cancer-clinic-a-prospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-link-between-p16-an-aging-biomarker-and-a-clinically-meaningful-functional-outcome-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-predictors-of-chronic-graft-vs-host-disease-in-bone-marrow-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-acute-myeloid-leukemia-and-chronic-lymphocytic-leukemia-a-review-and-clinical-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-antecedent-myelodysplastic-syndrome-treatment-on-outcomes-and-treatment-response-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitor-ppi-pharmacogenomics-pgx-on-toxicities-associated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclaxazacitidine-vs-intensive-chemotherapy-as-a-bridge-to-allogeneic-hsct-in-aml-experience-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-car-t-cell-therapy-versus-allogeneic-stem-cell-transplantation-in-relapsedrefractory-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/public-health-policy-and-cancer-prevention-impact-of-hpv-vaccine-laws-on-oropharyngeal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-sensitivity-patterns-across-fab-subtypes-and-molecular-mutations-in-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-gender-disparities-in-the-prevalence-of-severe-ards-among-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-characteristics-and-outcomes-of-systemic-mastocytosis-sm-patients-pts-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-real-world-data-sources-for-clinical-oncology-research-a-review-of-studies-published-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-body-mass-index-and-overall-survival-in-veterans-receiving-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-risk-of-multiple-primary-malignancies-in-esophageal-cancer-survivors-incidence-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-implementing-the-clinical-trial-navigator-program-a-qualitative-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-outpatient-rehabilitation-services-on-physical-function-and-potential-risk-of-unplanne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-use-and-health-care-utilization-in-an-academic-center-a-retrospective-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacoeconomic-analysis-of-perioperative-chemo-immunotherapy-in-resectable-stage-iii-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-sequencing-every-core-needle-biopsy-by-addressing-one-gap-at-a-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcome-based-weight-management-versus-usual-care-during-induction-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-combined-with-sintilimab-and-sox-as-first-line-treatment-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-of-women-with-breast-cancer-regarding-patient-navigation-services-served-at-the-western-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-seeking-care-for-the-initial-diagnosis-of-melanoma-in-an-urban-safety-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-trial-of-nano-crystalline-megestrol-acetate-for-nutritional-improvement-in-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metronomic-therapy-as-a-favorable-independent-factor-for-survival-in-high-risk-oral-cavity-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-chemotherapy-or-apatinib-in-the-first-line-treatment-of-recurrent-or-metastatic-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-time-to-treatment-discontinuation-among-advanced-alk-positive-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-and-disparities-in-laryngeal-cancer-mortality-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-expression-level-in-a-large-cohort-from-an-indian-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-genomic-profiles-targeted-treatment-use-and-overall-survival-in-patients-with-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-early-palliative-care-integration-on-healthcare-utilization-in-patients-with-newly-diagnos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-immune-microenvironment-and-spatial-phenotypes-across-her2-subtypes-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-language-gap-in-palliative-oncology-a-translation-and-validation-of-the-urdu-version-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-immunopathological-evaluation-and-its-comparison-with-consensus-molecular-subtypes-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-relevance-of-starting-alectinib-at-a-reduced-dose-in-patients-with-alk-positive-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-transcriptome-signatures-and-cd103cd8-immune-infiltration-for-prognosis-and-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-nk-cell-dysfunction-and-ilc-imbalance-as-drivers-of-immune-evasion-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-and-lifestyle-associated-risk-factors-on-outcomes-of-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-cell-free-dnas-to-identify-molecular-characteristics-related-to-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-multicenter-blank-controlled-phase-iv-clinical-trial-of-biyan-qingdu-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-gas-associated-with-durability-of-benefit-from-trastuzumab-deruxtecan-t-dxd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/image-harmonization-for-pd-l1-immune-checkpoint-inhibitor-response-prediction-using-radiomic-featu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-circulating-tumor-dna-landscape-in-young-onset-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-outcomes-of-follicular-dendritic-cell-sarcoma-with-or-without-castlem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-experiences-in-managing-antibody-drug-conjugate-dosing-adjustments-due-to-nausea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dabrafenib-and-trametinib-in-the-treatment-of-braf-mutated-anaplastic-thyroid-cancers-atc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-cellular-interactions-in-the-tnbc-tumor-microenvironment-in-association-with-pd-l1-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-adding-cureety-remote-patient-monitoring-rpm-to-usual-care-during-injectable-anticancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-sepsis-related-mortality-among-patients-with-malignancies-a-25-year-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-generative-ai-models-performance-on-patient-education-quizzes-hormone-related-sympto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sociodemographic-and-clinical-factors-on-time-to-treatment-initiation-in-adult-soft-tissue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-deferoxamine-in-patients-with-leptomeningeal-metastases-phase-1a-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-state-variations-and-temporal-trends-in-tracheal-bronchus-and-lung-cancer-burden-in-india-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anxiety-depression-fear-of-cancer-recurrence-fcr-and-health-related-quality-of-life-hrql-in-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-low-dose-5-mg-versus-8-mg-dexamethasone-with-nepa-for-the-168-h-prevention-of-highly-or-moder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cell-proliferation-pathway-on-accessibility-to-targeted-therapeutics-in-the-spectrum-of-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-progression-decision-score-to-improve-subsequent-treatment-regimen-selection-after-init 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profile-of-hepatocellular-carcinoma-hcc-in-older-oa-versus-younger-adults-ya-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-clinical-study-of-4th-generation-btk-inhibitor-hbw-3220-capsules-in-patients-with-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-cfdna-based-protein-informed-epigenetic-signature-pep-sig-to-enable-biomarker-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-oncogenic-potential-of-p53-amyloids-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-perioperative-or-only-adjuvant-gemcitabine-plus-nab-paclitaxel-for-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-resident-education-in-ambulatory-oncology-a-targeted-needs-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulated-t-cell-exhausted-subtypes-to-predict-response-in-pdac-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-albumin-bound-paclitaxel-and-s-1-as-first-line-treatment-of-her-2-negative-unresec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-carboplatintaxane-cbt-with-or-without-doxorubicincyclophosphamide-ac-in-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-olutasidenib-in-patients-with-iidh1i-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-spatial-expression-of-cldn182-in-gastric-cancer-and-gastroesophageal-junction-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-postoperative-adjuvant-therapy-and-surgery-alone-in-pathological-n1-2-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-transarterial-chemoembolization-followed-by-sintilimab-anti-pd-1-oxaliplatin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-pt-characteristics-treatment-patterns-and-outcomes-in-unresectable-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodology-for-estimation-of-progression-free-survival-in-patients-with-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-us-veterans-aged-80-with-newly-diagnosed-diffuse-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-quality-of-life-qol-in-patients-pts-with-metastatic-renal-cell-carcinoma-mrcc-on-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-induction-chemoimmunotherapy-with-surgery-and-concurrent-chemoradiation-followed-by-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-landscape-of-lynch-syndrome-associated-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-study-of-real-world-clinical-outcomes-in-patients-with-cllsll-previously-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-lycat-in-egfr-tki-resistance-nsclc-progression-and-smoking-induced-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-high-dose-vitamin-c-as-adjunct-treatment-in-gastric-and-colorectal-cancers-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-landscape-in-patients-with-squamous-cell-carcinoma-of-the-anal-canal-scac-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-scoring-systems-in-first-line-chemotherapy-combined-with-immunotherapy-unique-predictive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-recombinant-newcastle-disease-virus-expressing-trail-to-overcome-resistance-and-enhance-apopt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penelope-a-randomized-phase-ii-trial-of-first-line-carboplatin-and-paclitaxel-in-combination-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-venous-thromboembolism-risk-in-hrher2-breast-cancer-patients-receiving-cdk46-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-proliferation-related-genes-as-predictive-factors-for-adjuvant-therapy-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rectal-arterial-infusion-chemotherapy-combined-with-anti-pd1-antibody-for-microsatellite-stable-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-matched-analysis-of-immunotherapy-alone-vs-chemotherapy-alone-in-stage-ii-iv-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-treatment-patterns-and-outcomes-of-advanced-gastrointestinal-stromal-tumor-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whos-on-the-podium-geographic-and-career-diversity-of-asco-annual-meeting-presenters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ramucirumab-in-pediatric-and-young-adult-patients-pts-with-relapsedrefractory-rr-desmoplastic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-8068-plus-adebrelimab-and-bevacizumab-for-advanced-hepatocellular-carcinoma-ahcc-a-phase-1b2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/value-of-tumor-mutational-burden-as-a-prognostic-factor-in-patients-with-non-small-cell-lung-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rhea-1-first-in-human-fih-study-of-azd9793-a-first-in-class-cd8-guided-t-cell-engager-tce-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-of-trastuzumab-deruxtecan-t-dxd-vs-physicians-choice-of-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-first-in-human-study-of-pfl-721stx-721-in-participants-with-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parpi-effectiveness-after-cdk46i-in-ibrca1i-and-ibrca2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/octreotide-scintigraphy-versus-dotatoc-pet-concordance-of-krenning-scores-and-implications-on-prrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-cancer-predisposition-genes-and-overall-survival-of-women-with-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-302-long-term-subgroup-analysis-from-the-phase-3-global-study-of-enfortumab-vedotin-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-trifluridinetipiracil-and-bevacizumab-combination-according-to-baseline-prog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-diagnosis-rates-lcdr-in-lung-cancer-screening-lcs-and-incidental-pulmonary-nodule-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-exercise-referral-practices-and-barriers-among-oncologists-in-public-and-private-inst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neopancone-gata6-expression-as-a-predictor-of-benefit-to-peri-operative-modified-folfirinox-in-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-datopotamab-deruxtecan-dato-dxd-rilvegostomig-in-advanced-or-metastatic-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-and-tolerability-of-immune-checkpoint-inhibitors-ici-for-the-treatment-of-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-designing-a-smartphone-based-navigation-system-for-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-helicobacter-pylori-eradication-on-prognosis-after-gastrectomy-for-gastric-cancer-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-racial-socioeconomic-disparities-and-outcomes-of-t-cell-prolymphocytic-leukemia-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-physician-perspectives-of-facilitators-and-barriers-in-clinical-trial-accrual-to-inform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-first-in-human-phase-1b-acceler8-001-study-of-s-531011-a-humanized-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ibi363-monotherapy-or-in-combination-with-bevacizumab-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-pod1um-201-a-phase-2-study-of-retifanlimab-a-humanized-anti-pd-1-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-value-of-baseline-psma-pet-total-tumor-volume-and-suv-mean-within-enza-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utidelone-in-combination-with-etoposide-and-bevacizumab-in-her2-negative-breast-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/technical-performance-of-the-l3-skeletal-muscle-index-in-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-guided-chemotherapy-optimization-using-real-time-evaluation-in-newly-diagnosed-dlbcl-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-expression-in-gastro-oesophageal-adenocarcinoma-in-a-western-population-overlap-with-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-differences-in-nonalcoholic-fatty-liver-disease-nafld-among-women-with-early-stage-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-for-patients-with-head-and-neck-squamous-cell-carcinoma-hnscc-treated-with-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-evaluating-safety-pharmacokinetics-and-efficacy-of-abbv-291-a-cd79 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-23-randomized-open-label-trial-of-bnt327pm8002-in-combination-with-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-brain-metastases-in-lung-cancer-patients-with-high-pd-l1-expression-gt50-compared 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-and-breast-cancer-risk-in-type-2-diabetes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-functional-dll3-expression-in-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-peri-operative-neoadjuvant-plus-adjuvant-study-of-fianlimab-anti-lag-3-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-oral-prostate-cancer-riptactherapeutic-in-phase-1-for-metastatic-castrate-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-immune-landscape-in-early-onset-colorectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-18f-dopa-pet-and-advanced-mri-on-treatment-response-assessment-in-idh12-mutant-gliomas-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-mfge8-expression-and-regional-localization-in-glioblastoma-tumor-samples-at-diagnosis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-cycles-of-neoadjuvant-therapy-with-low-dose-radiotherapy-pd-1-inhibitor-tislelizumab-albumin-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-an-early-response-indicator-in-anal-squamous-cell-carcinoma-treated-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-elderly-patients-age-over-70-years-with-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-incidence-among-indigenous-adults-in-brazil-a-19-year-analysis-of-hospital-cancer-registry-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-iii-double-blind-randomized-trial-of-bnt327pm8002-plus-chemotherapy-chemo-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-outcomes-of-lymphoma-directed-car-t-cell-therapy-in-patients-with-and-without-hiv-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-olomorasib-immunotherapy-in-first-line-treatment-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-palliative-care-intensity-of-end-of-life-care-and-their-impact-on-overall-survival-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disruptive-advances-in-exosome-lyophilization-unlocking-new-frontiers-in-precision-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-sotorasib-response-duration-and-identification-of-clinically-actionable-resistance-mec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-review-of-additional-primary-cancers-in-breast-cancer-patients-from-a-tumor-registry-of-a-large-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-determinants-of-palliative-care-utilization-among-hospitalized-patients-with-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-accounting-of-comprehensive-radiotherapy-life-cycle-assessment-components-in-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-size-doesnt-fit-all-early-outcomes-of-implementing-the-asco-pga-in-an-australian-public-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-initial-abemaciclib-dosing-with-duration-of-medication-use-in-patients-with-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcomes-of-rejection-in-solid-organ-transplant-recipients-treated-with-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-landscape-of-sarcoma-patients-treated-with-an-autologous-dendritic-cell-vaccine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-kidney-toxicity-management-and-outcomes-in-ici-treated-patients-with-advanced-or-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-circulating-tumor-dna-and-microbial-landscapes-in-nasopharyngeal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-acute-and-chronic-toxicities-from-adjuvant-therapies-post-resection-of-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-neck-lymphadenectomy-at-surgical-treatment-of-papillary-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ai-informed-biomarkers-of-spatial-organization-of-tumor-infiltrating-lymphocytes-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-followed-by-chemoradiotherapy-with-cisplatin-or-cetuximab-for-unresectable-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishment-and-validation-of-a-dynamic-prognostic-model-using-serial-circulating-tumor-dna-ctdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ehrs-and-a-phenome-wide-association-study-to-identify-pre-diagnostic-clinical-markers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnosis-treatment-and-outcomes-of-multiple-myeloma-in-armenia-a-real-world-experience-from-a-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-amyloidosis-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-in-patients-with-metastatic-uveal-melanoma-undergoing-isolated-hepatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fc-engineered-anti-cd9-antibodies-with-reducing-platelet-toxicity-and-efficacy-against-acute-lymphob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteinuria-with-preserved-renal-function-pprf-a-retrospective-cohort-study-in-newly-diagnosed-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-oral-cavity-cancer-recurrence-in-pakistan-findings-from-a-cross-sectional-study-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-webcam-based-tool-to-assess-tongue-motility-and-its-correlation-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advance-care-planning-documentation-prior-to-end-of-life-systemic-therapy-a-single-institution-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-radioactive-iodine-refractory-rair-differentiated-thyroid-cancer-dtc-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicentric-evaluation-of-an-artificial-intelligence-model-to-stratify-stage-ii-colon-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cetuximab-plus-tislelizumab-combined-with-chemotherapy-in-pmmr-rasbraf-wild-type-wt-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-analysis-of-proteins-in-the-development-of-breast-cancer-brain-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-primary-endocrine-resistance-through-ctdna-profiling-of-a-hybrid-real-world-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-epithelioid-hemangioendothelioma-ehe-insights-into-common-and-organ-specific-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-analysis-of-phase-ibii-trial-of-durvalumab-plus-doxorubicin-combination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-discontinuation-in-desmoid-tumors-factors-associated-with-better-outcomes-after-sorafenib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-ipsc-derived-mesenchymal-stem-cells-i-mscs-to-secrete-il-7il-15-for-modulation-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-of-lung-adenocarcinomas-from-the-safir02-lung-trial-explores-metastasis-associate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-opioid-prescription-fills-following-cancer-directed-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tackling-healthcare-provider-bias-in-care-and-research-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-of-voice-a-decision-support-tool-for-older-adults-with-advanced-cancer-a-pilo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-single-center-investigator-initiated-exploratory-clinical-study-in-patients-with-refra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-lung-cancer-a-post-covid-era-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-in-control-arms-of-clinical-trials-analysis-of-fda-cancer-drug-approvals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-on-reactive-cutaneous-capillary-endothelial-proliferation-following-camrelizu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phasex-patient-tumor-avatars-for-evaluating-anticancer-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/achieving-equity-in-genomic-testing-for-breast-cancer-through-partner-led-strategies-and-policies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunochemotherapy-for-locally-advanced-esophageal-squamous-cell-carcinoma-pooled-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-cancer-impacts-adolescents-and-young-adults-ayas-scholastic-experiences-insight-on-supporti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-mortality-trends-and-disparities-in-women-of-the-united-states-a-two-decade-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-disease-progression-on-health-related-quality-of-life-hrqol-updated-results-from-the-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-scores-a-phase-iii-randomized-double-blinded-placebo-controlled-study-of-suvemc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-combined-with-the-intra-arterial-infusion-of-bevacizumab-for-bclc-stage-b-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-trends-in-mortality-from-breast-cancer-and-cerebrovascular-diseases-in-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-among-patients-referred-externally-for-clinical-trials-in-a-large-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equity-analysis-of-clinical-oncology-treatment-pathways-usage-in-an-integrated-health-care-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gentian-violet-compared-with-methylene-blue-for-sentinel-lymph-node-biopsy-in-breast-cancer-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-insurance-based-inequities-in-oncotype-dx-testing-and-score-guided-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-efficacy-and-safety-of-ponatinib-in-acute-lymphoblastic-leukemia-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-between-patients-with-breast-cancer-with-and-without-hiv-at-jaramogi-oginga-odi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-and-disparities-in-leukemia-mortality-in-the-united-states-1999-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-metastatic-cancer-curable-a-survey-of-medical-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-we-still-choosing-wisely-predictors-of-unnecessary-staging-imaging-in-us-veteran-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-and-prevalence-of-benign-ethnic-neutropenia-ben-in-breast-cancer-patients-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-the-prostest-a-novel-blood-based-molecular-assay-versus-psa-for-prostate-cancer-stratif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-initial-and-subsequent-indications-of-new-oncology-drugs-a-us-canada-comparison 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-characteristics-and-clinical-outcomes-of-driver-mutant-oligometastatic-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-mutations-in-non-small-cell-lung-cancer-real-world-data-and-clinical-insights-from-a-tertiary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-outcomes-in-mcrpc-the-impact-of-androgen-receptor-inhibitor-sequencing-before-177lu-psma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mhc-class-i-expression-and-outcomes-in-breast-cancer-in-the-real-world-clinico-genomic-data-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-on-first-line-1l-treatment-for-46-advanced-lung-adenocarcinoma-patients-harbour 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-combined-with-cytarabine-ma-for-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-signatures-ges-derived-from-digital-histology-to-predict-pathologic-complete-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-ibrcai-status-on-clinical-outcomes-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mathematical-modeling-applied-to-the-growth-and-invasion-of-gliomas-a-narrative-review-of-methods-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-barriers-facilitators-and-best-practices-for-optimal-provider-to-provider-communication-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-hernia-risk-in-renal-cell-carcinoma-rcc-patients-treated-with-tyrosine-kinase-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-glioblastoma-therapy-with-a-recombinant-newcastle-disease-virus-harboring-the-pten-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-proteomics-based-approach-for-detection-of-esr1-mutant-peptides-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-and-postoperative-risk-prediction-models-based-on-perirenal-fat-and-immune-infiltration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-agnostic-therapies-in-a-high-volume-brazilian-center-real-world-challenges-and-opportunities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-analysis-of-pathological-prognostic-factors-related-to-lymphovascular-invasion-lvi-and-perineu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-in-advanced-biliary-tract-cancers-a-meta-analysis-of-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-tace-with-or-without-pd-l1-inhibitors-for-the-treatment-of-unresectable-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-public-and-private-ovarian-cancer-register-in-chile-potential-effect-of-national-formulary-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-and-chidamide-in-combination-with-gemox-as-first-line-treatment-for-advanced-and-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-local-therapy-in-chinese-patients-with-bclc-stage-c-hepatocellular-carcinoma-hcc-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-appropriate-therapeutic-sequence-with-angiogenesis-inhibitor-and-chemotherapy-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-glioblastoma-care-insights-from-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-disparities-by-implementing-a-supportive-care-program-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-testing-in-newly-diagnosed-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-fairness-and-mitigating-bias-in-models-predicting-financial-toxicity-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-locally-advanced-inoperable-nsclc-patients-converted-to-resectable-disease-by-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-treatment-patterns-and-clinical-outcomes-among-patients-with-primary-medias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-proteomic-predictors-of-sites-of-metastases-in-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-ishox2i-and-irassf1ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-characteristics-and-outcomes-of-diffuse-large-b-cell-lymphoma-in-adolescents-and-young-adu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-of-adjuvant-molecularly-targeted-therapy-and-immunotherapy-for-resected-stage-ib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-odronextamab-in-non-hodgkin-lymphoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-carotuximab-env105-mediated-cd105-blockade-on-osimertinib-sensitivity-in-egfr-mutant-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cataloging-genomic-and-transcriptomic-features-of-relapsed-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cancer-specific-survival-for-early-onset-gastric-cancer-insights-from-a-21-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-morbidity-and-role-of-mammographic-screening-program-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-pygl-with-chicoric-acid-to-normalize-glucose-metabolism-to-inhibit-progress-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-systemically-administered-innate-immune-modulator-on-anti-tumor-activity-against-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-incidence-and-prevalence-of-gastric-cancer-among-older-adults-70-from-1990-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-pharmacodynamic-and-prognostic-potential-of-fap-activity-assessed-through-fap-media 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-personalized-prognosis-in-appendiceal-ac-and-cecal-adenocarcinoma-ca-with-machine-lear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recognizing-international-medical-graduates-awards-and-committee-membership-in-asco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-artificial-intelligence-driven-selection-of-doublet-chemotherapy-regimens-as-second-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/residents-understanding-of-cancer-prognosis-does-the-level-of-training-or-oncology-rotation-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overview-of-endocrine-malignancies-in-jordan-insights-from-the-mena-region 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-eosinophilia-as-a-potential-biomarker-of-response-and-immune-related-adverse-events-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-effectiveness-of-palbociclib-in-indian-patients-with-breast-cancer-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variation-in-mortality-from-digestive-system-cancers-in-peru-during-the-period-2001-2020-and-its-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-dietary-cholesterol-serum-lipids-and-cancer-specific-mortality-in-us-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-homologous-recombination-repair-pathway-germline-ngs-gene-variants-in-a-tnbc-rich-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-recurrence-risk-from-clinicopathologic-features-in-hrher2-early-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-first-line-chemo-immunotherapy-and-chemotherapy-on-es-sclc-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substudy-g-of-the-canadian-cancer-trials-group-cctg-ind234-pc-bets-v-a-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ai-for-validating-the-association-between-minimal-residual-disease-mrd-and-survival-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tigos-trial-a-randomized-double-blind-phase-3-trial-of-atigotatug-nivolumab-fixed-dose-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-carfilzomib-lenalidomide-and-dexamethasone-isa-krd-for-high-risk-hr-newly-diagnose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-subcutaneous-versus-intravenous-administration-of-pd-l1-inhibitors-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-predictive-role-of-tumor-sidedness-in-irasi-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-machine-learning-risk-prediction-models-for-detection-of-early-onset-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-tqb2102-in-women-with-locally-advanced-or-early-her2-positive-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-ai-model-for-predicting-germline-brca12-mutations-from-hrher2-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematological-malignancies-in-the-united-states-what-do-mortality-trends-reveal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pod1um-303interaact2-subgroup-analyses-and-impact-of-delayed-retifanlimab-treatment-on-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-immune-related-adverse-events-associated-with-immune-checkpoint-inhibitors-a-pharmacovigila 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-numbers-dissecting-racial-and-gender-disparities-in-myeloma-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-sup18sup-ffluoroestradiol-fes-petct-to-guide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-artificial-intelligence-mmai-model-to-identify-benefit-from-2nd-generation-androgen-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-surgical-and-treatment-patterns-after-neoadjuvant-checkpoint-inhibition-in-us-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-response-to-immunotherapy-in-pancreatic-ductal-adenocarcinoma-pdac-with-homologous-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-metastatic-egfr-mutation-positive-nsclc-patients-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-predictive-impact-of-pd-l1-expression-on-immunotherapy-outcomes-and-immunophenotype-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-pembrolizumab-in-combination-with-cisplatin-or-carboplatin-and-pemetrexed-as-induc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-somaticgermline-homologous-recombination-repair-hrr-alterations-on-metastatic-hormone-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-lisocabtagene-maraleucel-liso-cel-versus-axicabtag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s1900e-a-phase-ii-study-examining-impact-of-co-mutations-on-sotorasib-for-previously-treated-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utract-registry-a-single-arm-multicenter-prospective-and-retrospective-registry-study-to-eva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-with-nivolumabipilimumab-with-or-without-iclostri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-a-small-molecule-c-myc-degrader-wbc100-in-solid-tumors-a-first-in-human-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-oncologist-reported-challenges-of-treating-metastatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-from-the-open-label-phase-2-trial-of-palbociclib-in-patients-with-advanced-well-dif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin182-specific-car-t-cells-satri-cel-versus-treatment-of-physicians-choice-tpc-for-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-response-in-patients-with-myelofibrosis-treated-with-pacritinib-in-real-word-clinical-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-open-label-randomized-study-of-rinatabart-sesutecan-rina-s-vs-investigators-choice-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-survival-of-anal-melanoma-an-analysis-of-the-united-states-national-cancer-datab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-mucosal-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-vs-somatic-brca-mutation-status-on-the-efficacy-of-rucaparib-vs-physicians-choic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lutetium-177-psma-617-in-oligo-metastatic-hormone-sensitive-prostate-cancer-bullseye-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-sex-and-survival-disparities-in-mycosis-fungoides-and-sezary-syndrome-a-seer8-database-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-vs-pivotal-trial-outcomes-of-imatinib-in-newly-diagnosed-chronic-myeloid-leukemia-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-lenvatinib-plus-pembrolizumab-for-resectable-clear-cell-renal-cell-carcinoma-pelur-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-sbrt-with-gm-csf-and-peg-ifna-to-induce-abscopal-effects-in-previously-treated-patients-wi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/change-in-t2-weighted-signal-intensity-change-in-tumor-volume-and-exposure-response-analysis-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-comparison-of-palbociclib-ribociclib-and-abemaciclib-in-patients-with-hrher2-abc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-status-with-secondary-primary-malignancy-risk-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-trk-fusion-lung-cancer-an-updated-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-dose-reduced-capmatinib-and-tepotinib-for-advanced-met-exon-14-skipping-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jskn003-a-biparatopic-anti-her2-antibody-drug-conjugate-adc-in-the-treatment-of-platinum-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-patients-pts-with-previously-treated-advanced-egfr-mutated-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nsclc-in-the-immunotherapy-era-trends-in-survival-and-disparities-across-demographic-and-socioecono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/starlite-1-phase-1b2-study-of-combination-sup177sup-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-01-safety-and-efficacy-of-bay-2927088-in-patients-with-advanced-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/10-year-follow-up-of-a-phase-2-clinical-trial-of-pembrolizumab-pembro-in-microsatellite-instabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-fatigue-as-a-common-adverse-effect-in-patients-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3cd3-t-cell-engager-obrixtamig-in-patients-with-extrapulmonary-neuroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-41-a-real-world-evidence-study-for-bladder-cancer-patients-treated-with-nadofaragene-firadenov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-post-chimeric-antigen-receptor-car-t-cell-monitoring-evidence-across-lisocabtagene-mar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hydroxyurea-vs-hypomethylating-vs-other-agents-in-chronic-myelomonocytic-leukemia-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meeting-enrollment-targets-in-imbrave152skyscraper-14-a-global-phase-3-study-in-patients-with-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glutaminase-isoform-expression-in-cancer-implications-for-metabolic-adaptation-and-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-pk-analysis-of-antibody-conjugated-liposome-encapsulating-doxorubicin-hf-k1-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/valor-study-a-phase-ii-trial-of-vorinostat-to-augment-response-to-177lutetium-psma-617-in-the-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-neoadjuvant-chemotherapy-nac-docetaxel-cisplatin-alone-dc-or-with-anti-human-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-her2-and-her2-low-metastatic-breast-cancer-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-normal-plasma-cell-biomarkers-after-arlocabtagene-autoleucel-arlo-cel-treatment-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-efficacy-of-cadonilimab-mono-or-combination-therapy-in-recurrentpersistentme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-fruquintinib-in-patients-with-metastatic-colorectal-cancer-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologus-dendritic-cell-vaccine-in-gbm-does-geography-matter-retrospective-analysis-from-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-informed-navigation-of-patients-in-persistent-poverty-zip-codes-to-improve-colorect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-plasma-biomarkers-with-recurrence-in-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-trial-of-intravesical-bh011-a-novel-docetaxel-formulation-in-patients-with-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-evidence-based-patient-centered-care-in-bladder-cancer-in-community-based-settings-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polygenic-risk-score-for-breast-cancer-in-the-thai-population-addressing-genetic-disparities-in-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revision-of-staging-system-for-natural-killer-t-cell-lymphoma-a-multicenter-study-from-the-chinese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-determinants-of-primary-refractory-metastatic-renal-cell-carcinoma-mrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-northstar-response-for-monitoring-mono-and-combination-immunotherapy-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-pts-with-microsatellite-stablemismatch-repair-proficient-msspmmr-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-transcriptomic-regulation-of-the-tissue-associated-microbiome-in-oncogenic-progression-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-weighted-ctdna-dynamics-for-precision-monitoring-of-relapse-risk-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bites-vs-icis-in-lymphoma-leukemia-and-myeloma-which-immunotherapy-reigns-supreme-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-inavolisib-inavo-weekly-paclitaxel-wp-in-patients-pts-with-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-c-reactive-protein-and-procalcitonin-in-risk-stratification-and-outcomes-of-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/steroid-receptor-expression-and-overall-survival-in-breast-cancer-patients-with-er-bone-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-prognostic-factors-of-patients-with-ewing-sarcoma-at-first-recurrence-following-modern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-withdrawal-without-a-defined-reason-in-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-changes-in-blood-indices-among-chronic-dialysis-patients-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-patterns-and-clinical-outcomes-after-anti-pd-1-therapy-failure-in-patients-with-cutaneou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gut-microbiome-in-pediatric-diffuse-midline-gliomas-correlative-study-results-from-the-pnoc022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-phase-study-enrollment-for-pediatric-oncology-patients-have-an-impact-on-symptom-burden-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-responses-in-555-advanced-nsclc-patients-enrolled-in-phase-i-studies-at-md-anderson-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-for-recurrentmetastatic-adenoid-cystic-carcinoma-a-multicenter-single-arm-phase-2-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-lrp1b-in-chemo-resistance-in-advanced-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-pembrolizumab-pembro-plus-plinabulin-plin-and-docetaxel-doc-for-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experiences-of-diagnosis-and-treatment-of-invasive-lobular-carcinoma-a-qualitative-study-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-mettl3-inhibition-in-pre-clinical-models-of-mds-and-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-docetaxel-oxaliplatin-and-capecitabine-for-untreated-metastatic-gastric-and-esoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pareto-principle-in-oncology-how-a-minority-of-countries-account-for-the-major-share-of-latin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-sintilimab-and-sox-as-conversion-therapy-for-initially-unresectable-gastricgastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-technology-enabled-clinical-trial-programs-impact-on-patient-screening-and-trial-enrollment-in-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-clinical-pharmacist-impact-on-reducing-total-cost-of-care-in-enhancing-oncology-model-enrolle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-breast-cancer-and-problems-of-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gift-that-keeps-giving-you-gifts-you-dont-want-mixed-methods-analysis-of-financial-toxicity-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-function-outcomes-in-female-patients-with-pelvic-cancers-treated-with-definitive-chemoradioth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-scoping-review-of-barriers-and-strategies-to-implementation-of-geriatric-assessment-in-olde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduction-of-postoperative-radiotherapy-in-head-and-neck-squamous-cell-carcinoma-a-single-arm-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-therapeutic-response-in-stomach-adenocarcinoma-by-integrating-hampe-and-rna-seq-using-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-environmental-burden-and-cancer-incidence-rates-across-population-subgroups-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-factor-severity-and-adverse-cardiovascular-events-a-report-from-the-childhood-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreax-artificial-intelligence-driven-diagnosis-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-early-detection-of-pancreatic-cancer-using-cfdna-methylation-marker-izfp30 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-of-trop2-nectin-4-and-her2-in-osteosarcomas-in-pursuit-of-a-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-therapy-for-initially-unresectable-intrahepatic-cholangiocarcinoma-a-multicenter-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-genetic-and-oncobiome-profiles-of-patients-with-nmibc-a-transcriptomic-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nanoliposomal-irinotecan-in-metastatic-pancreatic-ductal-adenocarcinoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-contemporary-trends-in-diagnosis-stage-and-treatment-outcomes-for-upper-tract-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyrosine-kinase-inhibitors-in-children-and-adolescents-with-recurrentrefractory-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cancer-fusionome-and-overexpressed-druggable-oncogenic-signals-in-ik-rasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-study-of-trastuzumab-biosimilar-ct-p6-and-chemotherapy-sox-or-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-and-neoadjuvant-efficacy-prediction-for-esophageal-cancer-using-cfdna-methylation-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-and-breast-cancer-survival-post-neoadjuvant-chemotherapy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-and-expansion-study-of-prame-t-cell-receptor-tcr-engineered-il15-transduce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-neo-irasi-wild-type-metastatic-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-locally-advanced-or-metastatic-radioiodine-refractory-differentiated-thyroid-cancer-rai-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-responses-in-ici-refractory-or-acquired-resistance-phase-2-study-of-np-g2-044-combined-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-innovative-evidence-based-laboratory-medicine-eblm-test-to-help-doctors-in-the-basic-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vascular-microenvironment-on-prognosis-in-hepatocellular-carcinoma-a-quantitative-feature 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omics-approach-using-lipids-and-proteins-for-early-detection-in-individuals-with-signs-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-hepatocellular-cholangiocarcinoma-a-population-based-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-investigation-of-an-early-detection-model-utilizing-cfdna-fragmentomics-for-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-cadonilimab-in-the-treatment-of-advanced-gynecological-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfox-haictace-combined-with-lenvatinib-plus-tislelizumab-as-a-conversion-therapy-in-initial-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-of-pr115002-a-novel-sortilin-targeting-peptide-drug-conjugate-in-platinum-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-fragmentomic-tumor-score-algorithm-for-enhanced-minimal-residual-disease-detection-and-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfirinox-the-best-adjuvant-treatment-for-ampullary-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-therapies-for-metastatic-pheochromocytoma-and-paraganglioma-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-informed-management-of-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adebrelimab-with-chidamide-gemcitabine-and-s-1-in-locally-advanced-or-metastatic-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-multicenter-single-arm-phase-ii-study-of-surufatinib-plus-sintilimab-and-ibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-metabolic-syndrome-and-colorectal-endometrial-and-breast-cancers-in-the-us-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospice-discharges-for-2022-among-patients-admitted-for-the-most-common-malignancies-an-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-impact-of-a-digital-care-platform-on-cancer-patients-in-india 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-prostate-cancer-local-recurrence-detection-an-analysis-of-optimal-imaging-modalities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-social-determinants-of-health-and-immunotherapy-utilization-in-patients-with-stage-iii-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-chemotherapy-dosing-on-subsequent-dosing-patterns-and-treatment-completion-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adequacy-of-immune-checkpoint-inhibitor-associated-thyroid-function-monitoring-following-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-and-communication-among-sexual-and-gender-minority-sgm-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-optimal-care-timeframes-for-culturally-and-linguistically-diverse-populations-and-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-busulfan-fludarabine-versus-busulfan-cyclophosphamide-as-a-conditioning-regim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-west-african-ancestry-reproductive-factors-and-deprivation-with-incidence-of-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-burden-quality-of-life-qol-social-and-behavioral-characteristics-in-young-patients-lt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-liver-to-life-the-overlooked-impact-of-masld-on-digestive-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/return-to-intended-oncologic-therapy-in-patients-with-metastatic-non-small-cell-lung-cancer-discharg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-metastatic-esophageal-and-gastroesophageal-junction-cancers-a-13-year-single-center-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-itp53i-mutations-and-variant-allelic-frequency-on-survival-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-outcomes-following-reduced-intensity-conditioning-haploidentical-hematopoiet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-spop-mutated-castration-resistant-prostate-cancer-crpc-treated-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-emerin-dysregulation-on-the-very-small-nuclear-phenotype-and-lineage-plasticity-associated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-chemotherapy-dosing-and-toxicity-results-from-the-optimal-breast-cancer-chemotherapy-dosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-ai-in-oncology-a-performance-comparison-of-chatgpt-4o-and-chatgpt-o1-in-neuroendocrine-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-cancer-history-with-markers-of-cognitive-decline-in-a-large-us-national-survey-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-diagnostic-accuracy-of-deep-learning-and-hand-crafted-radiomics-models-for-detecting-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-halp-score-as-a-prognostic-biomarker-in-non-small-cell-lung-cancer-a-comprehensive-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-effusion-lymphoma-in-human-immunodeficiency-virus-hiv-negative-population-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-sepsis-in-patients-with-diffuse-large-b-cell-lymphoma-insights-from-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-prognostic-indicators-in-wilms-tumor-using-machine-learning-techniques 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphoma-in-sub-saharan-africa-report-from-an-oncology-centre-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunodriver-1-driver-alterations-dalts-and-their-immunological-implications-in-early-and-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-clostridium-butyricum-combined-with-neoadjuvant-chemoimmunotherapy-in-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-venetoclax-and-ibrutinib-in-relapsedrefractory-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-dose-escalation-and-cohort-expansion-phase-iiia-study-of-acr246-an-innovative-5t4-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-targeted-therapy-versus-immunotherapy-in-metastatic-colorectal-cancer-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-based-on-sequencing-of-fruquintinib-regorafenib-and-tas-102-with-or-without-bevac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observation-or-adjuvant-therapy-the-optimal-regime-for-patients-undergoing-neoadjuvant-chemoradioth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-lung-cancer-in-india-insights-from-a-precision-oncology-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-cdk46-inhibitor-in-metastatic-hormone-receptor-positive-breast-cancer-insights-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-neoadjuvant-immunochemotherapy-and-identification-of-residual-cancer-cells-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-plasma-biomarkers-with-diagnostic-molecular-markers-for-potential-diagnosis-and-progn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-idh-mutation-and-1p19q-codeletion-on-immune-checkpoint-inhibitor-efficacy-in-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-between-open-and-minimally-invasive-hepatic-resections-for-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-sglt2i-dapagliflozin-in-primary-prevention-of-cardiotoxicity-induced-by-short-term-anthra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herthena-breast03-a-phase-2-randomized-open-label-study-evaluating-neoadjuvant-patritumab-deruxte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/textbook-outcomes-after-esophagectomy-a-five-year-of-experience-at-a-specialized-centre-in-a-develo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-for-primary-carcinomas-of-the-liver-in-the-pediatric-and-younger-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-monocentric-real-word-experience-of-ct-io-combination-in-advanced-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-socioeconomic-disparities-in-barretts-esophagus-and-esophageal-cancer-mortality-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-dissection-on-prognosis-in-esophageal-squamous-cell-carcinoma-patients-undergoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retinoblastoma-patient-outcomes-in-the-contemporary-era-the-riverboat-consortium 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-bai3-as-a-potential-biomarker-for-lung-cancer-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-i-trial-of-the-sirpa-monoclonal-antibody-bi-770371-alone-and-in-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-demographics-clinical-features-and-outcomes-of-early-onset-colon-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-needs-and-considerations-for-implementing-a-community-based-palliative-care-program-for-women-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-multimodal-analgesic-management-based-on-the-eras-concept-in-the-periope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-inhaled-corticosteroids-on-immune-checkpoint-inhibitor-pneumonitis-and-mortality-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-lu177-fapi-09-therapy-in-combination-with-chemotherapy-or-immunotherapy-for-chemo-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-declining-renal-function-on-multiple-myeloma-mm-mortality-in-the-us-1999-2023-a-reg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-glioblastoma-survival-a-seer-based-study-of-demographics-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologically-interpretable-pathomics-driven-transformer-model-with-self-supervised-training-for-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/competencies-for-practicing-medical-oncology-with-common-sense-a-global-curricula-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lymphopenia-rescue-and-ca19-9-levels-with-overall-survival-following-il-15-superagoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-in-patients-pts-with-advanced-urothelial-carcinoma-auc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practical-geriatric-assessment-pga-implementation-strategies-and-correlative-evaluations-pace-70 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-combined-with-donafenib-and-tislelizumab-versus-transcatheter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/administration-of-tarlatamab-in-an-outpatient-setting-utilizing-remote-patient-monitoring-mayo-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modification-of-the-novel-rano-clinical-risk-score-for-low-and-middle-income-countries-without-acce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ono-4578-an-ep4-antagonist-in-combination-with-nivolumab-after-chemoradiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-multicenter-clinical-trial-to-evaluate-the-safety-and-efficacy-of-abenacianine-for-injection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-alcohol-intake-and-health-related-quality-of-life-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-two-decade-analysis-of-gastric-cancer-mortality-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incident-reporting-and-outcomes-of-gastrointestinal-adverse-events-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-from-ovarian-cancer-in-women-of-the-united-states-a-21-year-analysis-of-trends-and-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-sacituzumab-govitecan-sg-vs-avelumab-monotherapy-as-first-line-1l-maintenance-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1ab-dose-escalationexpansion-study-of-bg-68501-a-selective-cdk2-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrutinib-venetoclax-plus-cd20-monoclonal-ab-initial-results-of-oasis-ii-a-prospective-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-glp1r-agonist-use-with-chemoimmunotherapy-for-early-stage-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/krascendo-2-a-phase-iii-study-of-divarasib-and-pembrolizumab-vs-pembrolizumab-and-chemotherapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-metabolic-syndrome-on-survival-among-patients-with-breast-or-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-propensity-matched-controlled-trial-evaluating-metformin-as-an-adjunct-to-neo-adjuvant-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-specific-factors-as-predictors-of-chemotherapy-induced-nausea-and-vomiting-insights-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-study-of-the-impact-of-trial-eligibility-criteria-on-enrollment-to-kras-g12c-inhibitor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-mt-303-an-innovative-in-vivo-mrna-chimeric-antigen-receptor-car-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-early-detection-and-monitoring-of-lung-cancer-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bisphosphonates-therapy-for-patients-diagnosed-with-multiple-myeloma-a-compr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melphalanhds-treatment-for-patients-with-hepatic-dominant-metastatic-uveal-melanoma-results-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-medically-tailored-meal-mtm-delivery-program-to-reduce-nutritional-decline-and-improve-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-a-personalized-ctdna-minimal-residual-disease-test-in-patients-undergoing-cura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-the-primarysecondary-prophylaxis-of-intermediate-risk-febrile-neutropeni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-prevalence-and-prognostic-significance-of-mtap-loss-in-endemic-nasopharyngeal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neosent-neoadjuvant-anti-pd-1-therapy-for-patients-with-high-risk-clinical-stage-ii-melanoma-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-analysis-of-pd-1-inhibitor-combined-with-chemotherapy-in-neoadjuvant-therapy-of-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-clinical-benefit-from-immune-checkpoints-and-baseline-radiomic-signature-in-inoperabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-gene-signatures-to-guide-hrher2-mbc-therapy-in-a-diverse-cohort-insight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hai-score-an-objective-her2-artificial-intelligence-method-for-accurate-h-score-estimation-from-ihc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-lesion-burden-as-a-predictor-of-progression-and-survival-in-smoldering-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-wide-rna-splicing-aberrations-and-their-potential-as-therapeutic-neoantigen-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-set-enrichment-analysis-of-melanoma-primary-tumor-transcriptome-to-identify-pathways-associated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-nab-paclitaxel-and-platinum-as-first-line-treatment-in-patients-with-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-comprehensive-genomic-profiling-cgp-in-head-and-neck-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-efficacy-in-triple-negative-breast-cancer-tnbc-patients-with-liv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-to-assess-the-safety-of-adjuvant-natural-killer-cell-injection-in-combination-with-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-i-study-of-non-viral-cd19cd22bcma-tri-targeting-jl-lightning-car-t-in-relapsedrefract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-role-of-indocyanine-green-icg-in-head-and-neck-cancer-surgeries-and-reconstructive-proce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-cardiotoxicity-in-breast-cancer-patients-treated-with-doxorubicintrastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-on-potential-cross-reactivity-between-hypersensitivity-reactions-to-taxanes-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-in-adolescents-and-young-adults-role-of-schools-in-raising-awareness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-to-evaluate-pattern-of-usage-of-immune-checkpoint-inhibitors-in-the-1st-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a022101nrg-gi009-a-pragmatic-randomized-phase-iii-trial-evaluating-total-ablative-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-tumor-immune-microenvironment-in-hispanic-and-african-american-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metformin-on-the-efficacy-of-immune-checkpoint-inhibitors-in-metastatic-melanoma-a-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-transposable-element-derived-neoantigens-in-atrx-mutated-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-for-identification-of-prognostic-genes-and-molecular-subgroups-in-pleural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-pembro-with-chemoradiotherapy-crt-as-treatment-for-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-prostaglandin-d2-signaling-axis-in-the-tumor-microenvironment-for-immune-modulation-and-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-prognostic-utility-of-cell-free-cfdna-tumor-fraction-tf-in-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-of-radium-223-ra-223-in-metastatic-castration-resistant-prostate-cancer-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qualitative-findings-from-providers-and-patients-for-planning-implementation-of-screening-clinical-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-mammography-among-transgender-and-gender-diverse-tgd-individuals-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-fibronectinp21-cdkn1a-functional-axis-in-breast-cancer-as-a-marker-of-an-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-a-shared-understanding-of-the-concept-of-cure-in-early-stage-treatment-of-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-immunotherapy-for-patients-with-advanced-or-metastatic-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-in-patients-with-primary-gastrointestinal-malignancy-on-anti-her2-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-racial-disparities-in-esophageal-cancer-admissions-comorbidities-and-outcomes-a-nationwid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-gastric-cancer-a-comparison-of-metastatic-and-locoregional-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-and-tumor-immune-cell-distribution-as-predictor-of-response-to-immune-checkpoint-blockade-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/likelihood-of-unplanned-readmission-among-oncology-patients-with-a-completed-post-discharge-follow-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-disparities-in-multiple-myeloma-and-cardiovascular-disease-mortality-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-three-month-survival-benefit-of-inpatient-chemotherapy-in-a-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positron-emission-tomography-with-computed-tomography-petct-and-minimal-residual-disease-mrd-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-increase-in-cme-consumption-associated-with-practice-change-in-the-real-world-an-empirical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-disitamab-vedotin-in-combination-with-pertuzumab-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-prediction-of-neoadjuvant-therapy-response-in-her2-positive-breast-cancer-throug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-breast-cancer-awareness-through-artificial-intelligence-bridging-the-gap-for-low-literacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-immune-dysregulation-in-aml-insights-from-integrated-genomic-and-transcriptomic-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cladribine-low-dose-cytarabine-and-venetoclax-alternating-with-azacitidine-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-transportation-services-on-completion-of-radiation-therapy-for-gynecologic-malignancie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/corticosteroid-cs-use-and-risk-of-adverse-events-aes-in-patients-pts-treated-for-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-at-an-nci-comprehensive-cancer-center-patterns-of-utilization-performance-and-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-prognostic-factors-associated-with-progression-free-survival-in-pts-with-metastatic-egfr-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-penpulimab-combined-with-taxanes-and-carboplatin-in-triple-negative-breast-cancer-a-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-resistance-on-first-line-egfr-directed-therapy-in-egfr-positive-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentation-landscape-of-cell-free-dna-in-patients-with-metastatic-castration-resistant-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-outcomes-with-sipuleucel-t-sip-t-among-black-men-with-metastatic-castrate-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clinical-trial-treatment-and-area-deprivation-index-in-the-outcomes-of-adolescent-and-youn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prescientai-an-ai-based-digital-histopathological-image-signature-for-risk-of-late-distant-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-accelerated-approval-oncology-drugs-subsequently-withdrawn-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-initiative-focused-on-biomarker-testing-in-stage-ib-iiia-resected-and-stage-iv-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-agnostic-automated-recist-measurements-across-time-points-with-foundation-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-minority-patients-a-tailored-education-initiative-for-clinical-trial-awareness-in-thorac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survivorship-and-caregiver-burden-in-multiple-myeloma-mm-using-machine-learning-ml-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telemedicine-enabled-synchronous-medical-oncology-and-home-hospice-visits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-screening-of-perception-of-curability-among-patients-with-advanced-cancer-a-longitudinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-antimicrobial-prophylaxis-and-infections-in-patients-with-acute-myeloid-leuke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-patient-communication-and-shared-decision-making-approaches-in-myeloproliferative-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-calibrated-lightgbm-machine-learning-model-to-predict-serious-adverse-events-in-oncology-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-therapeutic-effect-of-interstitial-brachytherapy-on-locally-inoperable-giant-osteosarcoma-masses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-anti-angiogenic-agents-to-chemotherapy-and-effects-on-progression-free-survival-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/institutional-experience-with-pancreatic-head-versus-bodytail-cancer-a-comparison-of-treatment-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bebt-209-a-primary-cdk4-inhibitor-in-combination-with-gemcitabine-and-carbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-specific-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-of-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-hidden-toll-defining-impacts-of-home-call-on-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-novel-compound-that-covalently-binds-to-the-hpv16-e6-protein-on-proliferation-of-hpv-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-predictors-of-adverse-clinical-outcomes-in-pancreatic-cancer-using-a-machine-learning-fra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-of-olutasidenib-post-transplant-maintenance-therapy-for-patients-with-id 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancies-spms-with-car-t-cell-therapy-in-rr-dlbcl-from-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-resonance-imaging-based-deep-learning-for-predicting-egfr-mutations-in-metastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cancer-screening-and-preventive-care-access-among-lgbtq-populations-a-cross-section 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinical-and-genomic-characterization-of-advanced-urachal-and-non-urachal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-inflammatory-markers-in-glioblastoma-a-meta-analysis-of-nlr-and-plr-stratified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ifitm3-with-the-efficacy-of-anti-pd1pd-l1-therapy-and-regulation-of-immunosensitivit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-syndrome-of-inappropriate-antidiuretic-hormone-secretion-siadh-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-capecitabine-with-cemiplimab-in-patients-with-hormone-receptor-positive-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-multicenter-open-label-study-of-hsk42360-a-brain-penetrant-braf-inhibitor-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-with-a-cdk46i-in-first-line-metastatic-hrher2-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-potential-biomarkers-for-folfiri-plus-aflibercept-as-second-line-treatment-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-study-evaluating-optimal-dose-efficacy-and-safety-of-e7386-lenvatinib-versus-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-homologous-recombination-deficiency-in-advanced-breast-cancer-treated-with-tras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cdk46-inhibitors-in-her2-positive-breast-cancer-a-systematic-review-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-longitudinal-patient-cohorts-using-hospital-electronic-medical-record-emr-data-via-secure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sinusoidal-obstruction-syndrome-and-other-outcomes-in-pediatric-patients-with-acute-lymphoblastic-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-accuracy-of-cell-free-dna-blood-based-tests-in-the-detection-of-gastric-cancer-an-exploratory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospero-a-phase-3-randomized-placebo-pbo-controlled-study-of-amezalpat-tpst-1120-a-peroxisom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-report-on-the-characterization-of-public-and-private-patients-with-ovarian-cancer-in-chile 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-52-gene-ngs-panel-combined-with-shallow-wgs-for-accurate-hrd-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-insights-from-164-patients-with-ovarian-granulosa-cell-tumors-an-18-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-therapies-for-unresectable-hepatocellular-carcinoma-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-decision-patterns-post-enfortumab-vedotin-plus-pembrolizumab-in-metastatic-urothelial-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-iii-study-of-abemaciclib-and-ramucirumab-in-metastatic-gastroesophageal-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-obesity-on-survival-in-non-small-cell-lung-cancer-patients-receiving-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-gut-gram-negative-antibiotic-resistant-colonization-dynamics-in-hematologic-cancers-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-patient-withdrawal-in-cancer-clinical-trials-a-systematic-evaluation-of-reasons-and-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-biomarker-of-pd-l1-expression-phenotypes-in-tumor-and-immune-cells-for-combined-pd-1-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-powered-complete-blood-count-panel-for-high-grade-cervical-lesion-identification-a-multicentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-and-its-correlation-with-survival-in-hormone-receptor-positive-her2-negative-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-influence-of-neutropenia-severity-on-mortality-and-adverse-outcomes-in-chemotherapy-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-and-therapeutic-vulnerability-of-rras-and-rras2-mutant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolving-landscape-of-academic-and-industry-partnerships-in-gynecologic-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-nci-designated-cancer-centers-medical-student-education-and-training-initiatives 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-maintenance-treatment-in-homologous-recombination-hr-proficient-hgsoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-characterization-of-uterine-carcinosarcoma-and-analysis-of-transcriptomic-shifts-in-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-reported-outcome-measure-prom-to-capture-patients-experiences-with-immuno-oncology-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-breast-cancer-a-post-covid-era-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-transportation-barriers-on-rural-cancer-patients-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delineating-the-role-of-the-microbiome-and-tumor-microenvironment-interactions-driving-mucosal-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-patients-at-high-risk-for-relapse-by-merlin-assay-cp-gep-in-an-independent-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u01e-a-phase-2-umbrella-study-with-rolling-arms-of-investigational-agents-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-inpatient-palliative-care-utilization-among-adolescents-and-young-adults-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-survivorship-care-coordination-between-primary-care-providers-and-cancer-care-clinicians 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicare-plan-switching-hospice-enrollment-and-place-of-hospice-services-at-the-end-of-life-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-gaps-evaluating-the-impact-of-urban-lung-cancer-screening-on-diverse-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-immunotherapy-early-treatment-failure-in-non-small-cell-lung-cancer-nsclc-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-bleeding-risk-in-hepatocellular-carcinoma-patients-treated-with-atezolizumabbevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-cabozantinib-atezolizumab-for-patients-with-advanced-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-treatment-of-multiple-myeloma-results-from-part-1-of-the-first-in-human-phase-12-dreamm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-open-label-multi-center-study-of-the-safety-tolerability-and-efficacy-of-iph4502-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/earlier-brain-tumor-detection-assessing-the-impact-on-survival-recurrence-inpatient-length-of-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multigene-ngs-assay-for-biomarker-identification-in-621-colorectal-cancer-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-infusion-of-allogeneic-double-negative-t-cells-as-immune-modulators-to-prevent-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-prospective-open-label-multi-center-single-arm-study-of-sasanlimab-plus-sacituzumab-go 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologic-correlates-of-circulating-tumor-dna-ctdna-shedding-in-the-intercept-colorectal-cancer-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-immediate-elevation-of-inflammatory-cytokines-after-platinum-pemetrexed-and-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-trial-of-radiotherapy-combined-with-doxorubicin-and-pd-1-antibody-for-localized-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-treatment-counseling-on-uptake-of-hormone-replacement-therapy-in-patients-undergoing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-analysis-of-ct-radiomics-and-clinical-variables-in-predicting-immunotherapy-response-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-to-assess-the-safety-and-efficacy-of-autologous-tumor-infiltrating-lymphocytes-lif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutralizing-antibodies-and-lymphocyte-count-as-biomarkers-in-patients-receiving-oncolytic-adenoviru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-by-race-among-men-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-difference-in-the-odds-of-development-of-bleomycin-pulmonary-toxicity-in-patients-with-germ-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-a-multicenter-phase-2-study-evaluating-the-efficacy-and-safety-of-arlocabtagene-auto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoimmunotherapy-with-afatinib-for-locally-advanced-head-and-neck-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estrogen-receptor-expression-in-residual-breast-cancer-following-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-caregiver-treatment-preferences-for-alk-non-small-cell-lung-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-response-based-clinical-trial-and-machine-learning-generated-real-world-end-points 2026-08-24 monthly 0.7 https://rjrindex.com/articles/attention-driven-multi-scale-analysis-for-accurate-tumor-classification-in-digital-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-changes-in-pediatric-aml-and-association-with-event-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-to-identify-high-risk-profiles-in-early-stage-melanoma-patients-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-in-advanced-intrahepatic-cholangiocarcinoma-using-pembrolizumab-combined-with-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-analysis-of-pd-1-inhibitor-combination-in-neoadjuvant-treatment-of-pmmrmss-rectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-depatuxizumab-mafodotin-abt-414-in-egfr-amplified-glioblastoma-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-hla-g-targeted-car-t-cells-ivs-3001-in-patients-with-advanced-hla-g-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-thymidine-kinase-activity-tka-as-a-potential-biomarker-in-the-sequential-immunotherapy-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-induced-dka-are-sugars-on-the-rise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-interventions-for-oral-toxicities-with-the-gprc5dcd3-bispecific-antibody-talquetamab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-benmelstobart-in-combination-with-chemotherapy-followed-by-sequential-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pansoho-phase-ii-trial-of-bay-2927088-in-patients-with-unresectable-or-metastatic-solid-tumors-othe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sosimerasib-monotherapy-in-patients-with-previously-treated-kras-g12c-mutated-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-following-melanoma-metastasectomy-categorized-by-response-to-immune-checkpoint-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ribociclib-rib-nonsteroidal-aromatase-inhibitor-nsai-in-natalee-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bmi-on-car-t-cell-therapy-outcomes-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immunotherapy-response-in-advanced-solid-tumors-using-quantitative-imaging-features-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-shortages-demand-action-policy-changes-to-protect-patient-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-cardiomyopathy-risk-prediction-in-survivors-of-childhood-cancer-using-electrocardiogram 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-genomic-profiling-of-cell-free-dna-cfdna-and-circulating-tumor-cell-dna-ctcdna-in-s1802 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-awt020-a-bifunctional-anti-pd-1il-2-fusion-protein-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrin-a-subvsub-v-sub3sub-targeted-ima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-determinants-of-immunotherapy-response-in-the-primary-tumor-of-clear-cell-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-omission-in-patients-with-clinically-node-negative-breast-cancer-undergoing-lumpectomy-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ziftomenib-in-relapsedrefractory-rr-inpm1i-mutant-acute-myeloid-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-camrelizumab-plus-apatinib-and-temozolomide-for-resectable-stage-iiiii-acral-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-kras-g12c-inhibitors-in-metastatic-pancreatic-cancer-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-letrozole-abemaciclib-and-metformin-in-estrogen-receptor-er-positive-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-obstructive-lung-diseases-affect-outcomes-in-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tirabrutinib-for-the-treatment-of-relapsed-or-refractory-primary-central-nervous-system-lymphoma-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-delay-castration-dc-an-open-label-multicenter-randomized-phase-3-study-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-metronomic-oral-vinorelbine-combined-with-pd-1-inhibitors-as-first-line-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-and-non-clear-cell-renal-cell-carcinomas-and-the-ability-to-engage-in-oxidative-phosphorylatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-and-clinical-performance-of-a-plasma-based-cgp-assay-neo-pantracer-lbx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-watch-and-wait-strategy-or-surgery-after-neoadjuvant-immunotherapy-for-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-duravelo-1-study-preliminary-results-of-nectin-4-targeting-zelenectide-pevedotin-bt8009 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathomics-based-prediction-of-thymic-epithelial-tumor-subtypes-within-the-french-rythmic-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-response-guided-neoadjuvant-sacituzumab-govitecan-and-pembrolizumab-sgp-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-emergent-resistance-to-sotorasib-plus-panitumumab-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-to-evaluate-the-safety-and-efficacy-of-ssgj-707-a-bispecific-antibody-targeting-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-liver-transplant-recipients-with-and-without-obesity-a-propensity-matched-analysis-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-to-predict-docetaxel-benefit-in-patients-with-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moving-beyond-the-traditional-two-step-approach-for-prognosis-prediction-the-bayesarc-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-inaticabtagene-autoleucel-in-chinese-patients-with-b-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/versatile-003-a-phase-3-randomized-open-label-trial-of-pds0101-and-pembrolizumab-compared-with-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoembolization-for-patients-with-uveal-melanoma-hepatic-metastasis-a-single-institution-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-classification-of-ifoxa1i-alterations-and-their-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-data-of-efficacy-and-safety-of-luvometinib-fcn-159-in-pediatric-participants-with-neurofib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-of-non-small-cell-lung-cancer-in-young-people 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-machine-learning-model-for-predicting-early-relapse-in-osteosarcoma-following-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cisplatin-plus-high-dose-infusional-5-fluorouracil-and-leucovorin-for-breast-cancer-bc-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-and-patient-demographic-disparities-among-breast-cancer-patients-across-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-merkel-cell-carcinoma-a-10-year-population-based-study-in-queensland-australia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liquid-biopsy-on-health-related-quality-of-life-in-cancer-treatment-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-adjuvant-toripalimab-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-and-drug-dependence-among-hospitalized-patients-with-cancers-of-the-lip-oral-cavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-characteristics-and-outcome-of-immune-checkpoint-inhibitor-renal-toxicities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-subtype-prevalence-and-the-impact-of-her2-directed-therapy-on-emergency-department-ed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bmi-on-cdk46-inhibitors-efficacy-and-safety-in-advanced-breast-cancer-results-from-a-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-psychological-intervention-on-perceived-distress-of-cancer-patients-results-from-a-longit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-sdoh-and-late-mortality-among-survivors-of-childhood-cancer-a-repor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cognitive-factors-with-lung-cancer-risk-in-the-uk-biobank-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-cellular-immunotherapy-using-vaccine-generated-neoantigen-specific-effector-t-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-resting-mast-cell-infiltration-in-the-sarcoma-microenvironment-with-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-benefit-risk-balance-of-second-line-therapies-for-hrher2-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-b440-an-oral-ibifidobacteriumi-engineered-wt1-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-exhaustion-and-pre-existing-t-cell-immunity-in-circulation-as-predictive-biomarkers-for-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-a-rare-complication-immune-checkpoint-inhibitors-icis-and-vogt-koyanagi-harada-vkh-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adapt-001-on-checkpoint-inhibitor-resistance-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-practice-patterns-for-lung-cancer-based-on-gender-insights-into-disparities-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-small-cell-lung-cancer-in-women-experience-of-the-national-institute-of-oncology-of-rabat-moro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-type-prediction-via-tissue-and-liquid-based-comprehensive-genomic-profiling-high-specificity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-knowledge-graph-generation-for-breast-cancer-using-open-source-llms-and-the-role-of-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-genetic-counseling-uptake-for-breast-pancreatic-and-prostate-cancers-at-a-safety-net-hos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-electronic-patient-reported-outcomes-epro-directed-virtual-model-for-addressing-oncology-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-disparities-in-patient-education-for-radiation-therapy-a-cross-sectional-survey-of-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-burden-in-the-us-1999-2023-rising-incidence-declining-mortality-and-regional-inequities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-pediatric-oncology-financial-toxicity-outcome-measure-with-content-and-face-validit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-inavolisib-inavo-alone-and-in-combination-with-endocrine-therapy-palbociclib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-promising-autologous-therapeutic-cancer-nanovaccine-on-tumor-associated-macrophages-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastroesophageal-reflux-disease-and-upper-aerodigestive-tract-cancer-risk-a-meta-analysis-of-site-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-efficacy-of-inavolisib-combined-with-anti-pd-1-or-anti-her2-antibody-in-treating-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematopoietic-stem-cell-transplant-in-multiple-myeloma-an-analysis-of-mortality-costs-and-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cyclin-e-overexpression-on-anti-tumor-immune-responses-via-activation-of-the-cgassting-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nvl-330-a-selective-her2-tyrosine-kinase-inhibitor-in-patients-with-advanced-or-metastatic-her2-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-and-predictive-value-of-the-immunological-gene-signatures-interferon-gamma-and-tide-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-evolving-therapeutic-landscape-of-stage-iv-lung-squamous-cell-carcinoma-a-13-year-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mantle-cell-lymphoma-updated-seer-analysis-from-2000-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflections-on-the-horse-trial-hyperthermic-intraperitoneal-chemotherapy-ibrcai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-a-clinical-nurse-specialist-led-enhanced-survivorship-and-early-palliative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-tumor-shed-markers-ai-driven-tumor-educated-polymorphonuclear-granulocytes-monitoring-for-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protein-bound-paclitaxelcarboplatin-compared-to-solvent-based-paclitaxelcarboplatin-in-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-stereotactic-ablative-radiotherapy-sabr-on-detection-of-ctdna-in-patients-with-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-cervical-cancer-patients-with-and-without-hiv-at-jaramogi-oginga-odinga-teac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neocircle-investigating-circulating-tumor-dna-dynamics-as-a-predictor-of-survival-in-primary-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-on-the-assessment-of-first-line-drug-efficacy-in-advanced-gastric-cancer-by-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-donafenib-combined-with-pd-1-checkpoint-inhibitor-for-patients-at-high-risk-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-and-supportive-care-practice-patterns-among-older-adults-with-metastatic-pancreatic-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-5methylthioadenosine-phosphorylase-imtapi-dele 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-race-ethnicity-and-nativity-on-distribution-and-outcomes-among-women-with-choriocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-mortality-and-length-of-hospital-stay-following-palliative-transarterial-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-values-of-sarcopenia-for-unresectable-hepatocellular-carcinoma-treated-with-transarterial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-deprivation-with-clinical-outcomes-among-hospitalized-patients-with-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-in-aya-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-risk-factors-for-the-development-of-pulmonary-hypertension-in-patients-with-myeloprolifera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncofertility-practice-patterns-in-nccn-cancer-centers-after-the-overturn-of-iroe-v-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-de-novo-oligometastatic-oligorecurrent-and-oligoprogressive-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-patient-outcomes-by-assessing-unmet-social-needs-a-preliminary-study-in-a-urologic-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-pharmacokinetics-of-mevrometostat-m-in-combination-with-enzalutamide-e-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgery-over-radiation-a-clear-path-for-malignant-phyllodes-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-execution-of-nationwide-molecular-tumor-boards-mtbs-in-resource-limited-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-on-epidemiology-biomarker-test-results-clinical-characteristics-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-mortality-from-hematological-malignancies-with-pulmonary-embolism-insights-from-us-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraoperative-radiation-therapy-versus-partial-breast-irradiation-for-early-stage-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-tiragolumab-and-atezolizumab-in-patients-with-relapsed-or-refractory-smarcb1-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-combined-with-albumin-bound-paclitaxel-and-cisplatin-in-the-neoadjuvant-therapy-for-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-effectiveness-of-immersive-virtual-reality-in-reducing-distress-in-patients-with-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-profile-of-novel-agents-targeting-immune-checkpoints-beyond-pd-1pd-l1-and-ctla-4-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-sarcopenia-and-surgical-timing-in-locally-advanced-esophageal-squamous-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-chemotherapy-allergy-to-tolerance-desensitization-as-a-safe-alternative-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-automated-dashboard-to-monitor-unplanned-reoperations-in-a-public-cancer-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/payers-perspectives-on-biosimilars-in-the-us-past-present-and-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-abemaciclib-and-niraparib-as-neoadjuvant-therapy-in-hormone-receptor-positive-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-access-barriers-for-patients-with-uterine-malignancies-results-from-a-single-center-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-a-latin-american-setting-with-first-line-osimertinib-in-egfr-mutated-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-protocol-phase-2-trial-of-re-treatment-with-177lu-psma-617-molecular-radiotherapy-for-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-pilot-of-a-culturally-responsive-cognitive-behavioral-intervention-prowess-for-black-and-lat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-ai-powered-spatial-analysis-to-predict-pathologic-complete-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-eluting-transarterial-chemoembolization-combined-with-anlotinib-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-priorities-care-for-older-breast-cancer-survivors-a-patient-centered-approach-to-improve-qu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-circulating-tumor-dna-among-taiwanese-early-breast-cancer-patients-undergoing-upf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/best-practices-and-key-barriers-for-light-chain-al-amyloidosis-patient-care-at-us-specialized-amyl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ovarian-function-suppression-ofs-containing-adjuvant-endocrine-therapy-in-premenopau 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-and-resource-utilisation-for-liquid-biopsy-vs-tissue-biopsy-genotyping-in-advanced-nsclc-a-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-lungflag-lean-machine-learning-model-to-identify-individuals-with-lung-cancer-using-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-endocrine-therapy-omission-on-survival-in-er-negative-pr-low-1-10-early-stage-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerability-and-outcomes-with-serial-cycles-of-28-days-of-venetoclax-in-newly-diagnosed-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/food-insecurity-and-disparities-in-mental-health-symptoms-and-severity-among-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-health-literacy-in-cancer-outpatients-receiving-oral-anticancer-drugs-and-followed-by-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-single-cell-genomics-with-scgpt-precision-clustering-and-genetic-insights-into-acute-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-a-vertically-integrated-health-system-on-the-disparity-of-socioeconomic-status-seen-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-geographical-and-socioeconomic-disparities-in-patients-with-rare-tumors-seer-database-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-delivering-early-palliative-care-via-video-versus-in-person-on-end-of-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-outcomes-by-prior-definitive-treatment-tx-in-patients-pts-with-high-risk-biochemically-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/research-productivity-of-international-medical-graduate-img-hematology-and-oncology-fellows-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-germline-genetic-testing-in-pancreatic-cancer-a-quality-improvement-project 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-radiotherapy-combined-with-tyrosine-kinase-inhibitors-in-the-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-targeting-chlorin-e6-heptamethine-cyanine-conjugates-theranostic-agent-for-cancer-imaging-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-pilot-oncology-summer-internship-on-early-medical-students-understanding-of-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-bgb-a317-plus-chemotherapy-ctchemoradiotherapy-crt-as-positron-emission-tom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-halc-combined-with-donafenib-and-immune-checkpoint-inhibitors-for-bclc-stage-c-hcc-patients-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-biomarker-analyses-utilizing-circulating-tumor-dna-in-advanced-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-cldn18-expression-in-a-western-biliary-tract-cancer-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-insights-into-pediatric-acute-myeloid-leukemia-in-resource-constrained-settin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-platinum-free-interval-in-advanced-endometrial-cancer-treatment-a-real-world-study-of-8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-male-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-spatial-transcriptomics-and-potential-mechanisms-of-intrinsic-resistance-to-her2-directed-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-features-of-biliary-tract-cancers-in-paired-tissues-and-ctdna-and-an-integrated-molecular-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spotlight-on-pre-chemotherapy-alpha-fetoprotein-and-survival-in-ovarian-yolk-sac-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ana-trial-development-of-a-diagnostic-test-and-dynamic-evaluation-of-ctdna-to-optimize-follow-up-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-gemcitabine-and-cisplatin-and-immune-checkpoint-inhibitor-ici-for-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-blood-transfusion-and-ovarian-cancer-survival-rates-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-allele-specific-analysis-of-germline-iatmi-altera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-based-screening-test-for-the-early-detection-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-survival-outcomes-in-infused-versus-not-infused-patients-with-aggressive-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eliminating-breast-surgery-for-triple-negative-or-hr-her2-breast-cancer-patients-with-clinical-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melody-a-prospective-non-interventional-multicenter-cohort-study-to-evaluate-different-imaging-guid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-trends-and-survival-outcomes-in-young-onset-vs-average-onset-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-neoplasms-of-central-nervous-system-demographic-and-geographical-disparities-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-parent-of-origin-predictions-for-hereditary-cancer-variants-using-proband-only-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-characteristics-of-mismatch-repair-mmr-protein-deficient-colorectal-cancer-crc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-an-ancestry-specific-variant-near-the-iesr1i-gene-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-versus-18f-fdg-pet-ct-in-predicting-long-term-disease-control-in-patients-with-advanced-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-prediction-of-post-transplant-survival-and-stratification-of-hcc-recurrence-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-practice-patterns-in-bone-marrow-biopsies-for-cutaneous-t-cell-lymphoma-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-or-focality-in-recurrent-low-grade-intermediate-risk-non-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-utilization-patterns-discontinuation-and-healthcare-resource-utilization-of-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-future-socio-economic-trends-in-hodgkin-versus-non-hodgkin-lymphoma-survival-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-and-adverse-events-with-adjuvant-osimertinib-in-resected-egfr-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-prediction-of-long-term-survival-in-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-posthumous-organ-donation-attitudes-a-comparative-study-of-egyptian-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-anal-adenocarcinoma-in-comparison-to-rectal-adenocarcinoma-a-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tratuzumab-deruxtecan-a-real-world-study-in-the-treatment-of-metastatic-breast-cancer-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opinions-of-real-world-clinicians-on-endocrine-resistance-in-hrher2-mbc-results-from-the-retract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molgen-detecting-new-dpyd-variants-for-the-safer-delivery-of-5fu-and-capecitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-nivolumab-maintenance-after-autologous-hematopoietic-stem-cell-transplantation-in-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-as-a-neoadjuvant-therapy-pre-liver-transplantation-for-hepatobiliary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-and-functional-mapping-of-the-suppressive-tme-in-primary-breast-tumor-and-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-surviving-beyond-2-years-post-allogeneic-stem-cell-transplantation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-first-line-bruton-tyrosine-kinase-inhibitors-btkis-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variable-response-rates-across-chemotherapy-regimens-for-severe-idiopathic-multicentric-castleman-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-overall-survival-of-head-and-neck-squamous-cell-carcinoma-in-the-us-seer-17-2018-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-dose-of-neoadjuvant-ipilimumab-and-nivolumab-in-resectable-melanoma-with-cd8-cell-imaging-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-effects-of-thc-on-migration-proliferation-and-tumor-growth-in-hpv-negative-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-iza-bren-bl-b01d1-an-egfr-x-her3-bispecific-antibody-drug-conjugate-adc-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inavo120-phase-iii-trial-final-overall-survival-os-analysis-of-first-line-inavolisib-inavoplac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immune-checkpoint-inhibitors-in-solid-organ-transplant-recipients-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp1-ra-with-pcsk9i-as-chemosensitizing-method-and-therapy-of-anthracycline-induced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-the-degree-of-satisfaction-and-quality-of-life-in-breast-cancer-patients-who-are-candidat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-steroid-prophylaxis-to-mitigate-crs-enhancing-access-to-bispecific-antibodies-in-rrmm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-serplulimab-and-bevacizumab-combined-with-nab-paclitaxelgemcitabine-followed-by-mfolfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-randomized-phase-ii-trial-to-assess-the-efficacy-and-safety-of-neo-adjuvant-olaparibcar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-vanguard-study-an-nci-cancer-screening-research-network-multi-cancer-detection-feasibility-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-early-onset-colorectal-cancer-a-retrospective-analysis-of-3369-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-medical-graduates-imgs-in-leadership-roles-within-academic-oncology-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-lenvatinib-plus-pembrolizumab-versus-placebo-plus-pembrolizumab-in-chinese-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shap-analysis-of-predictive-factors-for-pathologic-complete-response-in-breast-cancer-patients-under 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-placebo-controlled-clinical-trial-of-can-2409prodrug-in-combination-with-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-plus-standard-of-care-soc-in-resectable-locally-advanced-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-the-ox40-agonist-bgb-a445-in-combination-with-docetaxel-or-bgb-15025-an-hpk1-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-specific-outcomes-in-patients-with-lynch-syndrome-treated-by-immune-checkpoint-blockade-for-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-combined-with-toripalimab-as-adjuvant-therapy-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjubil-a-phase-ii-study-of-immunotherapy-with-durvalumab-and-tremelimumab-in-combination-with-cape 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-persistent-disparities-in-incidence-mortality-and-survival-of-pancreatic-cancer-a-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-pulmonary-toxicities-in-patients-with-egfr-mutant-non-small-cell-lung-cancer-nsclc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-large-language-models-for-matching-cancer-patients-to-biomarker-driven-clinical-trials-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-tolerability-and-efficacy-of-bry812-in-patients-with-advanced-solid-tumors-preliminary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-cns-results-from-a-randomized-subset-of-the-phase-2-savannah-study-comparing-savolitini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secn-15-a-novel-treatment-option-for-patients-with-checkpoint-inhibitor-resistant-tumors-by-targeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-young-onset-rectal-cancer-is-the-latinx-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-mortality-and-incidence-trends-for-tumor-lysis-syndrome-in-the-united-states-from-2016-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-results-from-an-ongoing-phase-iii-trial-of-cts2190-a-prmt1-inhibitor-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dareontm-9-a-phase-ib-study-of-obrixtamig-plus-topotecan-in-patients-pts-with-advanced-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-iza-bren-bl-b01d1-an-egfr-x-her3-bispecific-antibody-drug-conjugate-adc-in-pa-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-in-patients-with-er-her2-advanced-breast-cancer-abc-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-dose-evaluation-of-nivolumab-relatlimab-nivo-rela-in-patients-pts-with-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathways-to-advance-targeted-and-helpful-serious-illness-conversations-path-sic-a-randomized-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/on-shift-resident-education-about-hematologic-and-oncologic-emergencies-a-needs-based-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-prophylactic-corticosteroids-on-toxicities-and-outcomes-in-car-t-cell-therapy-a-cohort-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-determine-the-mechanism-behind-cancer-risk-reduction-with-glucagon-like-peptide-1-receptor-ag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/desmoplastic-nodular-medulloblastoma-a-national-cancer-database-analysis-of-patient-demographics-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-pre-operative-durvalumab-medi-4736-in-early-small-triple-negative-breast-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-therapy-in-relapsedrefractory-alk-lymphomas-previously-treated-with-tyrosine-kinase-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-analysis-of-3-y-results-from-the-pivotal-epcore-nhl-1-study-outcomes-in-patients-pts-with-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-patterns-of-care-in-ovarian-carcinoma-patients-with-brain-metastases-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-assessment-in-patients-with-advancedmetastatic-renal-cell-carcinoma-using-routine-data-coll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-car-t-cell-therapy-and-bite-therapy-in-relapsedrefractory-diffuse-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-receipt-of-guideline-concordant-treatment-for-early-stage-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daily-a-prospective-single-arm-study-evaluating-the-impact-of-vitamin-d-aspirin-exercise-and-die 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-value-of-carbon-nanoparticle-staining-in-identifying-metastatic-lymph-nodes-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-modulations-during-cyclic-fasting-mimicking-diet-in-patients-with-advanced-solid-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-cytotoxic-effects-of-bioactive-compounds-from-ialcea-roseai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-clinical-and-molecular-characteristics-of-braf-mutated-mss-crc-and-impact-of-inflammat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dalpiciclib-plus-fulvestrant-and-pyrotinib-in-hr-her2-low-advanced-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-pathologist-directed-comprehensive-comparative-molecular-profiling-for-the-class 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-to-identify-no-evidence-of-disease-status-in-advanced-breast-cancer-with-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-magnetic-bead-based-cfdna-extraction-method-for-advanced-ctdna-marker-discovery-and-methylat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-screening-updates-across-paraguay-evaluation-of-the-national-cancer-control-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-surgery-based-comprehensive-treatment-on-prognosis-of-stage-iiic-cervical-squamous-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-modeling-based-on-radiomics-and-hematological-parameters-for-recurrence-free-survival-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-in-vitro-and-in-vivo-evaluation-of-novel-anxv-chemo-protein-drug-conjugate-against-human 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-obese-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-inp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-among-liver-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-zg005-with-etoposide-and-cisplatin-ep-vs-ep-as-the-first-line-therapy-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-zg005-a-bispecific-antibody-targeting-pd-1-and-tigit-in-combination-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radio-genomics-analysis-of-contrast-enhanced-mri-for-predicting-therapeutic-response-to-lenvatinib-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-immunohistochemistry-for-mismatch-repair-testing-on-endometrial-intraepithelia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-non-canonical-role-of-homologous-recombination-deficiency-in-the-development-of-immune-cold-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-study-examining-disparities-in-the-administration-of-immunotherapy-among-advanced-cervical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-monitoring-to-reveal-early-predictors-of-immunotherapy-success-in-advanced-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-hardship-and-non-adherence-to-lifestyle-and-surveillance-recommendations-in-adult-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-bcma-targeted-therapies-in-relapsedrefractory-rr-multiple-myeloma-mm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-randomized-double-blinded-placebo-controlled-trial-of-ifx-hu20-ifx-as-adjunctive-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-status-and-genomic-characteristics-of-chinese-nsclc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-access-to-triple-negative-breast-cancer-tnbc-clinical-trials-are-trials-located-near-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-immunogenomic-profile-of-anal-hpv-driven-disease-for-novel-therapeutic-discovery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-prevalence-management-and-outcomes-of-synchronous-oligometastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-fine-particulate-matter-exposure-and-colorectal-cancer-mortality-by-age-at-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-in-liver-limited-metastatic-colorectal-cancer-mcrc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-plasma-proteomic-analysis-a-monitoring-strategy-for-nsclc-patients-treated-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-cutaneous-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-vaccination-recommendations-in-the-adult-cancer-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-place-of-death-among-breast-cancer-patients-in-the-united-states-1999-2023-a-25-year-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/snf-climedin-a-hecog-prospective-randomized-trial-of-digital-support-and-intervention-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protocol-quality-for-patient-reported-outcomes-in-multiple-myeloma-randomized-controlled-trials-acco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-quality-perception-among-cancer-survivors-impact-of-provider-time-spent-and-shared-deci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barbados-first-next-generation-sequencing-of-a-prostate-cancer-sample 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bep-in-intermediate-and-poor-risk-advanced-non-seminomatous-germ-cell-tumor-nsgct-standing-the-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-a-patient-registry-and-novel-follow-up-protocol-to-impact-identification-treatment-and-adher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-tissue-genomic-sequencing-and-high-purity-circulating-tumor-cell-rna-sequenci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/right-care-right-place-improving-urgent-care-for-breast-cancer-patients-on-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-efficacy-and-safety-of-fruquintinib-plus-paclitaxel-versus-paclitaxel-in-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-real-world-impact-of-atezolizumab-and-bevacizumab-combination-in-unresectable-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-signatures-as-predictive-biomarkers-for-chemotherapy-ct-resistance-and-survival-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematology-oncology-education-in-postgraduate-internal-medicine-programs-in-nepal-current-status-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-hpv-test-with-urine-cytology-in-bladder-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-diversity-in-neuroendocrine-tumors-a-house-divided 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moments-of-connection-between-clinicians-and-patients-in-oncology-a-mixed-methods-exploratory-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-healthcare-costs-and-family-support-coping-strategies-adopted-by-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-homologous-recombination-related-gene-mutations-in-survival-outcomes-of-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-data-management-in-clinical-trials-uncovering-crc-pain-points-through-user-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-hrd-profiling-in-chinese-pancreatic-ductal-adenocarcinoma-imp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-adjuvant-chemo-immunotherapy-in-pancreatic-cancer-results-of-the-australasian-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-versus-chemotherapy-in-metastatic-urothelial-carcinoma-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-neoadjuvant-chemoimmunotherapy-with-chemotherapy-in-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-venadaparib-plus-irinotecan-in-homologous-recombination-deficiency-hrd-gene-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-albumin-bound-paclitaxel-and-enhancement-of-anti-pd-1-therapy-in-bladder-cancer-by-shaping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-mismatch-repair-deficient-colorectal-cancer-a-retrospective-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-profiling-of-the-tumor-microenvironment-in-asian-american-and-native-hawaiianpacifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-trial-of-onvansertib-in-combination-with-nalirifox-for-first-line-treatment-of-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-trial-of-s-1-and-paclitaxel-in-combination-followed-by-5-fluorouracilepirubicinc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/receiving-a-cancer-diagnosis-during-hospitalization-and-associations-with-care-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-neoadjuvant-chemotherapy-combined-with-anti-angiogenesis-therapy-and-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-prophylactic-thrombopoietin-combined-with-magnetic-resonance-guided-hematopoieti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-alter-e00-study-efficacy-and-safety-of-anlotinib-combined-with-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-by-type-of-insurance-in-the-journey-of-cervical-cancer-care-within-the-context-of-univer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/loss-of-anpep-expression-may-promote-the-development-of-aggressive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elucidating-contributions-to-burden-of-disease-in-cns-progression-for-egfr-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mytrialist-reach-and-utilization-a-novel-digital-cancer-clinical-trial-finder-and-education-platfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-hematological-parameters-and-outcomes-in-patients-with-prostate-cancer-treated-with-lu-177 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implications-for-sentinel-lymph-node-biopsy-slnb-omission-in-patients-with-early-stage-node-negati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utility-of-genomic-profiling-in-prostate-cancer-insights-from-a-phase-i-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-analysis-of-myelofibrosis-mf-patient-subgroups-by-baseline-hemoglobin-levels-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-parpi-related-mdsaml-risk-in-breast-cancer-patients-an-international-collab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-prostate-radiation-therapy-and-survival-among-patients-with-metastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-need-in-adults-and-adolescents-and-young-adults-ayas-with-b-cell-acute-lymphoblastic-leukemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-healthcare-system-distrust-in-shaping-patients-attitudes-and-beliefs-of-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-receipt-of-surveillance-breast-mri-among-raciallyethnically-diverse-women-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/achieving-global-breast-cancer-initiative-key-performance-indices-for-breast-cancer-patients-in-bots 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-food-and-drug-administration-based-eligibility-criteria-on-demographic-representation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-circadian-rhythms-and-chemotherapy-safety-in-remote-patients-with-pancreatic-ductal-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/common-criticisms-of-the-accelerated-approvals-program-a-context-and-data-driven-assessment-of-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-social-and-time-toxicity-in-early-phase-cancer-clinical-trials-the-pearler-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-socio-economic-deprivation-and-cancer-trial-participation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetismm-32-a-phase-3-randomized-study-of-elranatamab-vs-epd-pvd-or-kd-in-patients-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-non-hodgkin-lymphoma-in-the-middle-east-and-north-africa-over-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-on-perioperative-treatment-strategies-of-driver-gene-positive-resectable-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-prognostic-factors-in-marginal-zone-lymphoma-a-single-center-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-non-ibrca12i-mutations-and-clinico-radio-pathologic-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-association-between-dietary-zinc-intake-and-cancer-risk-insights-from-nhanes-2021-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sogug-neowin-a-phase-2-open-label-multicenter-multinational-interventional-trial-evaluating-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-to-evaluate-clinical-efficacy-pharmacodynamics-and-exploratory-analysis-of-pemetre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biomarker-analyses-of-first-line-nivolumab-and-relatlimab-nivo-rela-in-advanced-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neotrace-a-multicenter-phase-ii-study-of-neoadjuvant-sacituzumab-govitecan-plus-zimberelimab-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-management-of-potentially-resectable-stage-ib-iiia-non-small-cell-lung-cancer 2026-08-24 monthly 0.7